Insider · CIK 0001544328

New Enterprise Associates 14, L.P.

CIK 0001544328 Name as filed on the most recent filing

Filed as New Enterprise Associates 14, L.P. (32)

60 transaction lines · from 32 filings · filed 2014-08-06 to 2022-04-07 The span is the filing dates this catalog holds, not the entity's full filing history. Absence here is not evidence of absence at the SEC.

How this page attributes a trade

A line appears here when the filing that carries it names this CIK as a reporting owner, not only when the parser picked this CIK as the line's primary owner. That is why a joint filing appears on both owners' pages rather than vanishing from the second one. The catalog never merges two CIKs into one person and never splits one CIK into two: identity here is the SEC's own identifier and nothing else.

01

Issuers this insider has filed against

Ordered by last-seen filing date, newest first. Roles are as filed on the Form 4 and are not normalised.

Fault

This container could not be filled from the store. It is showing nothing because a read failed, not because no insider filed: those are different facts and this catalog will not let one stand in for the other. The last ingest the store recorded was 2026-08-21 05:23 UTC.

No issuer is recorded

The catalog holds no filing linking this CIK to an issuer.

02

Transactions

Every stored Form 4 line naming this reporting owner, newest transaction date first. Each row links to the filing it came from.

2 transactions · Newest transaction date first, id breaking the tie.

Fault

This container could not be filled from the store. It is showing nothing because a read failed, not because no insider filed: those are different facts and this catalog will not let one stand in for the other. The last ingest the store recorded was 2026-08-21 05:23 UTC.

Transactions filed by this insider
Direction Date Issuer Code Shares Price Value USD Filing
2022-04-06 Imara Inc.
IMRA
S, Open-market sale 255,463 disposed 1.10 281,826.78 Form 4, filing 0001209191-22-023686
2022-04-05 Imara Inc.
IMRA
S, Open-market sale 439,088 disposed 1.07 469,428.98 Form 4, filing 0001209191-22-023686
2022-01-25 Imara Inc.
IMRA
S, Open-market sale 102,952 disposed 1.47 151,802.72 Form 4, filing 0001209191-22-004877
2022-01-24 Imara Inc.
IMRA
S, Open-market sale 19,984 disposed 1.55 31,017.17 Form 4, filing 0001209191-22-004877
2022-01-21 Imara Inc.
IMRA
S, Open-market sale 11,622 disposed 1.67 19,388.98 Form 4, filing 0001209191-22-004877
2022-01-20 Imara Inc.
IMRA
S, Open-market sale 6,295 disposed 1.81 11,385.14 Form 4, filing 0001209191-22-004110
2022-01-19 Imara Inc.
IMRA
S, Open-market sale 13,412 disposed 1.82 24,413.86 Form 4, filing 0001209191-22-004110
2022-01-18 Imara Inc.
IMRA
S, Open-market sale 6,848 disposed 1.89 12,926.97 Form 4, filing 0001209191-22-004110
2022-01-14 Imara Inc.
IMRA
S, Open-market sale 9,707 disposed 1.91 18,583.08 Form 4, filing 0001209191-22-003357
2022-01-13 Imara Inc.
IMRA
S, Open-market sale 7,209 disposed 1.93 13,885.98 Form 4, filing 0001209191-22-003357
2022-01-12 Imara Inc.
IMRA
S, Open-market sale 4,634 disposed 2.02 9,357.44 Form 4, filing 0001209191-22-003357
2022-01-11 Imara Inc.
IMRA
S, Open-market sale 2,409 disposed 2.04 4,919.42 Form 4, filing 0001209191-22-002930
2022-01-10 Imara Inc.
IMRA
S, Open-market sale 1,751 disposed 2.00 3,502.00 Form 4, filing 0001209191-22-002930
2022-01-07 Imara Inc.
IMRA
S, Open-market sale 14,600 disposed 2.08 30,318.36 Form 4, filing 0001209191-22-002930
2022-01-06 Imara Inc.
IMRA
S, Open-market sale 10,257 disposed 2.16 22,205.38 Form 4, filing 0001209191-22-002224
2022-01-05 Imara Inc.
IMRA
S, Open-market sale 8,200 disposed 2.25 18,439.34 Form 4, filing 0001209191-22-002224
2022-01-04 Imara Inc.
IMRA
S, Open-market sale 13,459 disposed 2.34 31,543.86 Form 4, filing 0001209191-22-002224
2022-01-03 Imara Inc.
IMRA
S, Open-market sale 44,665 disposed 2.34 104,395.50 Form 4, filing 0001209191-22-000354
2021-12-31 Imara Inc.
IMRA
S, Open-market sale 49,953 disposed 2.25 112,409.24 Form 4, filing 0001209191-22-000354
2021-12-30 Imara Inc.
IMRA
S, Open-market sale 21,858 disposed 2.29 50,065.75 Form 4, filing 0001209191-22-000354
2021-12-29 Imara Inc.
IMRA
S, Open-market sale 15,196 disposed 2.30 34,953.84 Form 4, filing 0001209191-21-071531
2021-12-28 Imara Inc.
IMRA
S, Open-market sale 24,580 disposed 2.34 57,539.32 Form 4, filing 0001209191-21-071531
2021-12-27 Imara Inc.
IMRA
S, Open-market sale 27,651 disposed 2.42 67,006.67 Form 4, filing 0001209191-21-071531
2021-12-23 Imara Inc.
IMRA
S, Open-market sale 23,961 disposed 2.41 57,746.01 Form 4, filing 0001209191-21-071262
2021-12-22 Imara Inc.
IMRA
S, Open-market sale 20,109 disposed 2.32 46,679.02 Form 4, filing 0001209191-21-071262
2021-12-21 Imara Inc.
IMRA
S, Open-market sale 41,222 disposed 2.32 95,804.05 Form 4, filing 0001209191-21-071262
2021-12-20 Imara Inc.
IMRA
S, Open-market sale 47,000 disposed 2.21 103,884.10 Form 4, filing 0001209191-21-071262
2021-12-20 Imara Inc.
IMRA
S, Open-market sale 38,123 disposed 2.33 88,719.85 Form 4, filing 0001209191-21-071262
2021-12-16 Imara Inc.
IMRA
S, Open-market sale 44,993 disposed 2.23 100,545.86 Form 4, filing 0001209191-21-071262
2021-12-15 Imara Inc.
IMRA
S, Open-market sale 28,817 disposed 2.28 65,685.47 Form 4, filing 0001209191-21-071262
2021-12-14 Imara Inc.
IMRA
S, Open-market sale 15,093 disposed 2.56 38,642.61 Form 4, filing 0001209191-21-071262
2021-12-13 Imara Inc.
IMRA
S, Open-market sale 17,501 disposed 2.83 49,557.58 Form 4, filing 0001209191-21-071262
2021-12-10 Imara Inc.
IMRA
S, Open-market sale 8,667 disposed 2.83 24,541.48 Form 4, filing 0001209191-21-071262
2021-12-09 Imara Inc.
IMRA
S, Open-market sale 5,666 disposed 2.95 16,693.17 Form 4, filing 0001209191-21-071262
2020-05-20 Surface Oncology, Inc.
SURF
S, Open-market sale 420,000 disposed 3.66 1,535,562.00 Form 4, filing 0001209191-20-031786
2020-03-16 Imara Inc.
IMRA
P, Open-market purchase 475,000 acquired 16.00 7,600,000.00 Form 4, filing 0001209191-20-019337
2020-03-06 Champions Oncology, Inc.
CSBR
S, Open-market sale 708,155 disposed 6.99 4,950,003.45 Form 4, filing 0001209191-20-017699
2020-02-10 Casper Sleep Inc.
CSPR
P, Open-market purchase 1,250,000 acquired 12.00 15,000,000.00 Form 4, filing 0001209191-20-008757
2019-11-12 Galera Therapeutics, Inc.
GRTX
P, Open-market purchase 416,666 acquired 12.00 4,999,992.00 Form 4, filing 0001209191-19-056068
2019-11-04 Oyster Point Pharma, Inc.
OYST
P, Open-market purchase 935,000 acquired 16.00 14,960,000.00 Form 4, filing 0001209191-19-055017
2019-08-28 Mersana Therapeutics, Inc.
MRSN
S, Open-market sale 1,211 disposed 2.91 3,524.01 Form 4, filing 0001209191-20-024272
2019-03-05 Mersana Therapeutics, Inc.
MRSN
P, Open-market purchase 3,750,000 acquired 4.00 15,000,000.00 Form 4, filing 0001209191-19-017378
2018-09-07 Adaptimmune Therapeutics PLC
ADAP
P, Open-market purchase 3,000,000 acquired 1.67 5,000,100.00 Form 4, filing 0001209191-18-050279
2018-04-23 Surface Oncology, Inc.
SURF
P, Open-market purchase 133,333 acquired 15.00 1,999,995.00 Form 4, filing 0001209191-18-025843
2018-03-27 Tracon Pharmaceuticals, Inc.
TCON
P, Open-market purchase 707,964 acquired 2.70 1,911,502.80 Form 4, filing 0001209191-18-021747
2018-03-27 Adaptimmune Therapeutics PLC
ADAP
P, Open-market purchase 6,000,000 acquired 1.92 11,500,200.00 Form 4, filing 0001209191-18-021936
2018-03-26 Adaptimmune Therapeutics PLC
ADAP
P, Open-market purchase 571,164 acquired 1.90 1,087,553.37 Form 4, filing 0001209191-18-021936
2018-03-23 Adaptimmune Therapeutics PLC
ADAP
P, Open-market purchase 294,090 acquired 1.95 572,357.96 Form 4, filing 0001209191-18-021542
2018-03-22 Adaptimmune Therapeutics PLC
ADAP
P, Open-market purchase 869,574 acquired 1.90 1,655,668.90 Form 4, filing 0001209191-18-021542
2018-03-21 Adaptimmune Therapeutics PLC
ADAP
P, Open-market purchase 104,844 acquired 1.81 189,820.06 Form 4, filing 0001209191-18-021542

This column is intentionally blank

No transaction line is stored for this reporting owner, though the catalog holds filings naming them. That happens when the filings report only holdings or only positions the store does not carry, and when a parse failed; each filing page states its own parse status.

Codes on this page
S, Open-market sale
Open-market sale
P, Open-market purchase
Open-market purchase

Every value is as reported on the Form 4. A price the filing did not report is marked Not reported and no value is computed from it. Codes outside the open market, drawn in grey behind a dashed rule, are compensation and administrative machinery rather than a decision to trade at the prevailing price.

What this insider's stored lines contain

Exact counts over every stored line for this entity. This is a statement of composition, not a filter: the only filter this page offers is the open-market one above, because that is the only one an index serves today.

  • Open-market purchase 2
  • Open-market sale 0
  • Option exercise 0
  • Grant or award 0
  • Tax withholding 0
  • Disposition to the issuer 0
  • In-the-money option exercise 0

How to cite this page

ebomi catalog. New Enterprise Associates 14, L.P., insider transactions. Retrieved 2026-08-21 from https://ebomi.com/insider/0001544328

Balogh, A. Insider trading. Scientific Data 10, 237 (2023) doi:10.1038/s41597-023-02147-6

This page as JSON The JSON twin is shaped by the same read model as this page, so the two cannot disagree. Its envelope carries the canonical URL, the retrieval time, the coverage claim, and the licence statement.